Related references
Note: Only part of the references are listed.Targeting human TLRs to combat COVID-19: A solution?
Ritwik Patra et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside
Kamal Kant Sahu et al.
LABORATORY MEDICINE (2021)
Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model
Pamela C. Proud et al.
EBIOMEDICINE (2021)
COVID-19: Developing from an Outbreak to A Pandemic
Sara Hanaei et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
COVID-19 pandemic: is a gender-defined dosage effect responsible for the high mortality rate among males?
Natasja G. de Groot et al.
IMMUNOGENETICS (2020)
In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs
Abhigyan Choudhury et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection?
Harald Murck
FRONTIERS IN IMMUNOLOGY (2020)
Bioinformatic analysis and identi fication of single -stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes
Mario Adan Moreno-Eutimio et al.
MICROBES AND INFECTION (2020)
Genetic gateways to COVID-19 infection: Implications for risk, severity, and outcomes
Monojit Debnath et al.
FASEB JOURNAL (2020)
COVID 19: a clue from innate immunity
Domenico Birra et al.
IMMUNOLOGIC RESEARCH (2020)
Presence of Genetic Variants Among Young Men With Severe COVID-19
Caspar I. van der Made et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences
Melika Lotfi et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment
Sebastiano Cicco et al.
MEDIATORS OF INFLAMMATION (2020)
Immune-mediated approaches against COVID-19
Helena F. Florindo et al.
NATURE NANOTECHNOLOGY (2020)
Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19
Athina Angelopoulou et al.
ENVIRONMENTAL RESEARCH (2020)
COVID-19: A Chimera of Two Pandemics
Parnian Jabbari et al.
DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS (2020)
SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology
Flavio Protasio Veras et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
The immune system and COVID-19: Friend or foe?
Fereshteh Yazdanpanah et al.
LIFE SCIENCES (2020)
Pathologic features of COVID-19: A concise review
Mohammadreza Tabary et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents
Sumanth Khadke et al.
VIROLOGY JOURNAL (2020)
Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective
Alaa Alnefaie et al.
SAUDI PHARMACEUTICAL JOURNAL (2020)
The Inflammasome in Times of COVID-19
Juan Carlos de Rivero Vaccari et al.
FRONTIERS IN IMMUNOLOGY (2020)
COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis
Kyung Mok Sohn et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
mTOR inhibition and p53 activation, microRNAs: The possible therapy against pandemic COVID-19
Mekala Janaki Ramaiah
GENE REPORTS (2020)
Interleukin-6 and severe COVID-19: a systematic review and meta-analysis
Helia Mojtabavi et al.
EUROPEAN CYTOKINE NETWORK (2020)
Implications of Toll-like receptors in Ebola infection
Amene Saghazadeh et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
Allison L. Totura et al.
MBIO (2015)
Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control
Prasannavenkatesh Durai et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Toll-Like Receptors in Antiviral Innate Immunity
Sandra N. Lester et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Protective Role of Toll-like Receptor 3-Induced Type I Interferon in Murine Coronavirus Infection of Macrophages
Liudmila Mazaleuskaya et al.
VIRUSES-BASEL (2012)
Targeting of Toll-like receptors: a decade of progress in combating infectious diseases
Mona Hedayat et al.
LANCET INFECTIOUS DISEASES (2011)
Recent insights into the role of Toll-like receptors in viral infection
M. Carty et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Share Paper
